TBI and melphalan followed by allogeneic hematopoietic SCT in children with advanced hematological malignancies

Bone Marrow Transplantation

Volumn 46, Issue 8, 2011, Pages 1057-1062

  Inagaki, J ^a   Nagatoshi, Y ^a   Sakiyama, M ^a   Nomura, Y ^a   Teranishi, H ^a   Sasaki, T ^a   Okamura, J ^a  

^a National Hospital Organization   (Japan)

Author keywords

children; hematopoietic SCT; melphalan; TBI

Indexed keywords

CYCLOSPORIN A; MELPHALAN; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; CANCER RELAPSE; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTINUOUS INFUSION; DISEASE FREE SURVIVAL; DRUG TOLERABILITY; ENCEPHALITIS; ENGRAFTMENT; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TOXICITY; LUNG TOXICITY; MALE; MUCORMYCOSIS; MULTIMODALITY CANCER THERAPY; NEPHROTOXICITY; NONHODGKIN LYMPHOMA; ORAL MUCOSAL DISEASE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SEPTICEMIA; STOMATITIS; TREATMENT DURATION; TREATMENT RESPONSE; VEIN OCCLUSION; WHOLE BODY RADIATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MELPHALAN; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION;

EID: 80051692214     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.253     Document Type: Article

References (26)

1. Davies SM, Wagner JE, Shu XO, Blazar BR, Katsanis E, Orchard PJ et al. Unrelated donor bone marrow transplantation for children with acute leukemia. J Clin Oncol 1997; 15: 557-565. (Pubitemid 27074222)
2. Woolfrey AE, Anasetti C, Storer B, Doney K, Milner LA, Sievers EL et al. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. Blood 2002; 99: 2002-2008. (Pubitemid 34525481)
3. Worth LL, Tran H, Petropoulos D, Culbert SC, Mullen CA, Roberts WM et al. Hematopoietic stem cell transplantation for childhood myeloid malignancies after high-dose thiotepa, busulfan and cyclophosphamide. Bone Marrow Transplant 1999; 24: 947-952. (Pubitemid 29532865)
4. Duerst RE, Horan JT, Liesveld JL, Abboud CN, Zwetsch LM, Senf ES et al. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclopho-sphamide. Bone Marrow Transplant 2000; 25: 489-494. (Pubitemid 30137862)
5. Cole CH, Pritchard S, Rogers PCJ, Davis JE, Phillips G, Chan KW. Intensive conditioning regimen for bone marrow transplantation in children with high-risk haematological malignancies. Med Pediatr Oncol 1994; 23: 464-469. (Pubitemid 24326454)
6. Tran HT, Madden T, Petropoulos D, Worth LL, Felix EA, Sprigg-Saenz HA et al. Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hemato-logic malignancies. Bone Marrow Transplant 2000; 26: 463-470.
7. de Lima M, van Besien K, Gajewski J, Khouri I, Andersson B, Korbling M et al. High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant. Bone Marrow Transplant 2000; 26: 333-338. (Pubitemid 30614416)
8. Matsuyama T, Kojima S, Kato K. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen. Bone Marrow Transplant 1998; 22: 21-26. (Pubitemid 28330531)
9. Small TN, Young JW, Castro-Malaspina H, Prockop S, Wilton A, Heller G et al. Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies. Biol Blood Marrow Transplant 2007; 13: 235-244. (Pubitemid 46115720)
10. Giralt S, Thall PF, Khouri I, Wang X, Braunschweig I, Ippolitti C et al. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood 2001; 97: 631-637. (Pubitemid 32113394)
11. Bordigoni P, Esperou H, Souillet G, Pico J, Michel G, Lacour B et al. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukemia after relapse while receiving chemotherapy: a Societe Française de Greffe de Moelle study. Br J Hematol 1998; 102: 656-665. (Pubitemid 28387046)
12. Murata M, Nishida T, Haneda M, Kanie T, Taji H, Iida H et al. A new preconditioning regimen with melphalan, busulphan and total body irradiation followed by low-dose immunosuppressant in allogeneic haematopoietic stem cell transplantation. Br J Hematol 1999; 105: 799-802. (Pubitemid 29277044)
13. Petropoulos D, Worth LL, Mullen CA, Madden R, Mahajan A, Choroszy M et al. Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematological malignancies. Bone Marrow Transplant 2006; 37: 463-467.
14. Bader P, Kreyenberg H, Henze GH, Eckert C, Reising M, Willasch A et al. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. J Clin Oncol 2009; 27: 377-384.
15. Gaynon PS, Qu RP, Chappell RJ, Willoughby MLN, Tubergen DG, Steinherz PG et al. Survival after relapse in childhood acute lymphoblastic leukemia. Cancer 1998; 82: 1387-1395.
16. Aladjidi N, Auvrignon A, Leblanc T, Perel Y, Benard A, Bordigoni P et al. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology. J Clin Oncol 2003; 21: 4377-4385. (Pubitemid 46621815)
17. Nemecek ER, Gooley TA, Woolfrey AE, Carpenter PA, Matthews DC, Sanders JE. Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia. Bone Marrow Transplant 2004; 34: 799-806. (Pubitemid 39467892)
18. Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562-1568. (Pubitemid 19092391)
19. Przepiorka D, Weisdorf D, Martin P, Klingemann H-G, Beatty P, Hows J et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
20. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217. (Pubitemid 10036817)
21. Boulad F, Steinherz P, Reyes B, Heller G, Gillio AP, Small TN et al. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study. J Clin Oncol 1999; 17: 197-207. (Pubitemid 29022394)
22. Eapen M, Raetz E, Zhang MJ, Muehlenbein C, Devidas M, Abshire T et al. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood 2006; 107: 4961-4967. (Pubitemid 43882651)
23. Schroeder H, Gustafsson G, Saarinen-Pihkala UM, Glomstein A, Jonmundsson G, Nysom K et al. Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries. Bone Marrow Transplant 1999; 23: 555-560. (Pubitemid 29137443)
24. Borgmann A, von Stackelberg A, Hartmann R, Ebell W, Klingebiel T, Peters C et al. Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis. Blood 2003; 101: 3835-3839. (Pubitemid 36857854)
25. Anasetti C, Petersdorf EW, Martin PJ, Woolfrey A, Hansen JA. Improving availability and safety of unrelated donor transplants. Curr Opin Oncol 2000; 12: 121-126. (Pubitemid 32043951)
26. Lee SJ, Vogelsang G, Flowers MED. Chronic graft-versus-host disease. Biol Blood Marrow transplant 2003; 9: 215-233. (Pubitemid 40045609)